Navigation Links
Lifecycle Biotechnologies Celebrates 40 Years of Business with its Boval BioSolutions Brand
Date:7/24/2018

Boval was founded in 1978 when Mr. Douglas Northcott began making bovine serum albumin (BSA) to support blood bank reagent suppliers. In Boval’s early days most of the BSA manufactured was for blood banking reagents; however, in the late 1980’s, lyophilization capabilities were added to produce BSA for diagnostic purposes after gel cards changed that market and displaced most of the large volume needs. Boval progressed on steadily until 2004’s, when Cody Yarborough purchased the company with an expectation to drive growth through new product development.

“Since acquiring the company, we have sparred with economic downturns, the emergence of giant competitors, hired a lot of people, and traveled the world looking for new markets and raw material sources,” said Cody Yarborough, Owner and Managing Member for Lifecycle Biotechnologies. “In that time, sales at Boval have quadrupled and our sales footprint has reached over 20 countries. When I look back since we acquired Boval, I think about how pivotal moments are tied together to bring us to where we are today. To reach 40 years as an independent company means you have to have great employees and great customers.”

From 2004 to today, Boval continued to evolve and launch products to expand and better support the markets it serves including…

  • the development and commercialization of BSA products for cell culture and regenerative medicine designed to provide superior growth promotion of mammalian cells when added to cell culture media as a supplement to increase the growth and productivity of cells and increase overall cell health,
  • production of Human Serum Albumin (HSA) products offered as an innovative and new cell culture grade of HSA and an alternative to the USP therapeutic grade HSA,
  • BSA products were again added as an anti-wrinkle component that produces a tightening effect on the skin when added to serums or creams for the personal care industry.

Boval’s longevity, innovative formulations, and extensive cell culture research from animal and non-animal derived proteins, combined with their unique testing capabilities for chemical, physical, and microbial purposes, have made them one of the world’s largest and foremost experts in Albumin.

To learn more about the Boval BioSolutions products or the other Lifecycle brands, Chata Biosystems and VI Plastics, and to experience for yourself the difference they can make for you and your facility, please contact Lifecycle Biotechnologies at info@lifecyclebio.com, 817.840.7855, or http://www.lifecyclebio.com.

Based in Ft. Worth, TX, Lifecycle Biotechnologies has served the life science industry for 40 years. Lifecycle’s products are the beginning of the lifecycle of the lifesaving and life-enhancing medical products used globally today. As a leading life sciences tools and service supplier, Lifecycle fully understands the critical role its products play in many of the world’s leading pharmaceuticals, medical devices, biologics, cell- and tissue-based products and many other medical products. While Lifecycle’s products aren’t used to diagnose, treat, or cure patients, without their contribution, none of this would be possible.

Read the full story at https://www.prweb.com/releases/2018/07/prweb15626769.htm.


'/>"/>
Source: PRWeb
Copyright©2018 Vocus, Inc.
All rights reserved


Related biology technology :

1. Technical Workshops at OrthoTec 2013 Focus on Risk Management Throughout Medical Device Lifecycle and Robust Material Selection Process Development
2. Patheon-Sponsored Event to Highlight “Product Enhancement Through Complex Dosage Forms: Adding Value to Products’ Lifecycle Management”
3. Wyle Wins NASAs Fully Integrated Lifecycle Mission Support Services Contract
4. Model of viral lifecycle could help in finding a cure for hepatitis B
5. PointCross announces SaaS offerings on the cloud to span the entire lifecycle of eData submissions to FDA
6. Lifecycle Biotechnology Today Announced the Hiring of Aaron Benz as Business Development Manager for their Chemical and Reagent Brand, Chata Biosystems
7. Bioclinica Introduces Pharmaceutical Industry’s First End-to-End Clinical Financial Lifecycle Platform
8. Lifecycle Biotechnologies Announces Promotion of Ashley Wilhelm to Customer Outcomes Manager
9. Adaptive Biotechnologies Signs Biomarker Discovery Collaboration Agreement with Bristol-Myers Squibb
10. TriLink BioTechnologies Announces Worldwide License with QuantiBact A/S, Copenhagen, Denmark
11. Dr. Gerald Jerry Zon Launches New Blog for TriLink BioTechnologies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/12/2019)... ... 2019 , ... An upcoming episode of Advancements with Ted ... and devices being used to enhance cognitive skills. This episode is scheduled to ... Advancements will focus on Sound for Life, a neurotechnology company helping people to ...
(Date:4/9/2019)... ... April 09, 2019 , ... The American Society of Gene & ... leadership team, including a new addition to the presidential line of succession, at the ... join the Society's leadership team for a three-year term (2019-2021). , All five incoming ...
(Date:4/4/2019)... ... 2019 , ... LeadingBiotech, an exclusive event series bringing biopharma ... Boston CEO conference to be held May 28-29, 2019 at Boston’s Four Seasons ... panels and discussions from past, present and future change-makers. , LeadingBiotech, ...
(Date:3/23/2019)... ... March 22, 2019 , ... uBiome has ... a team of researchers at Nnamdi Azikiwe University in Anambra State, Nigeria led ... PhD, of the Department of Medical Laboratory Sciences and Deputy Provost, College of ...
Breaking Biology Technology:
(Date:5/21/2019)... (PRWEB) , ... May 21, 2019 , ... Experiential tourism, ... rise in demand over the last several years. And according to a recent ... down anytime soon. In fact, more and more travelers are wanting their journeys ...
(Date:5/21/2019)... ... May 20, 2019 , ... Pennsylvania College ... announced a 96.15% pass rate for first-time test takers of the National Council ... average of 76.43% by nearly 20 points. , “This first-time pass rate ...
(Date:5/14/2019)... ROCKVILLE, Md. (PRWEB) , ... May 14, 2019 ... ... today an expansion of their business strategy beyond immuno-oncology into areas of autoimmunity, ... autologous human T cell and tumor cell lines for IO discovery efforts. ...
Breaking Biology News(10 mins):